ARC Desk

Next Generation Sequencing Market Competitive Status,Trend and Forecast to 2026

Lehdistötiedote   •   Tammi 02, 2020 12:28 EET

The global next generation sequencing market size is set to reach over US$ 20.4 billion by 2026 and will grow at CAGR 18.7% during the forecast period 2019-2026. Acumen Research and Consulting, Latest Research Report on titled “next generation sequencing market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 – 2026”.

In the coming years, the global next generation sequencing market will continue exhibiting growth at a stable pace. The report offers a comprehensive overview of the market, covering growth drivers as well as restraints. It reveals hidden opportunities across key segments. Furthermore, the report highlights prevailing threats in the market. It is compiled with the most relevant information on the market to help companies determine their future growth strategies.

Information thus included in the report is obtained using diverse primary and secondary research methods. The report also includes interview of industry veterans. Their opinion is given due weightage in the study. In addition to this, the report includes statistics taken from various international organizations. This is done with the intent of studying the global market for the period starting from 2019 to 2026. These figures are reached using in-depth qualitative and quantitative analysis.

Competitive Landscape

In order to offer an executive level blueprint of the global next generation sequencing market, the report studies in detail the prevailing competitive landscape. The nature of competition prevailing in the global market is studied. Factors resulting into competitive rivalry among leading players are gauges as well. In this section, the report includes information obtained from various companies. Information on their product portfolio and pricing strategy is included in this section. Furthermore, the report highlights the impact of strategies adopted by these companies on this market.

Bargaining power of supplier and buyers are calculated using Porter’s five forces analysis. Furthermore, the study, helps at calculating the threat from close substitutes as well as new entrants.

Download a Free Sample Copy@ https://www.acumenresearchandconsulting.com/request-sample/1642

List of Companies

To offer a comprehensive overview, the report profiles some of the most prominent names in the industry. The market share of the global next generation sequencing market is dominated by companies like BGI, Bio-Rad Laboratories, Inc., DNASTAR, Inc., Eurofins GATC Biotech GmbH; F Hoffman-La Roche Ltd., Genomatix GmbH, Illumina Inc.; Oxford Nanopore Technologies, Perkin Elmer, Inc., PierianDx, Inc., QIAGEN, and Thermo Fisher Scientific, Inc. They are studied on the basis of their corporate policies, product portfolio, pricing strategies, recent mergers and acquisition, and various other criteria. Furthermore, recent developments witnessed in these companies in terms of recent investment, product launches, and collaborations are studied in the report in detail.

The strengths and weaknesses of the companies profiled are studied in detail. Furthermore, the report offers scope for analysing threats and opportunities existing in the market for the companies profiled.

Geography

The global next generation sequencing market can be segmented into Europe, Asia Pacific, North America, Latin America, and the Middle East and Africa.

Among key regional segments, the market is likely to witness lucrative growth opportunities in developed economies. The presence of a well-developed healthcare network is expected to support the growth of the market in these countries. Developed countries have attained the status of early adopters. While several leading companies have presence here, they are gradually shifting focus to capitalize on the prevailing opportunities in the emerging nations.

Various factors are supporting the growth witnessed across these countries. Firstly, the rise in spread of awareness is expected to bode well for the next generation sequencing market in emerging economies. Furthermore, in Asia Pacific government support towards the sector as well as investment towards expanding the healthcare and pharmaceutical industries is increasing. This is expected to drive the next generation sequencing market in Asia Pacific.

To offer an executive-level blueprint, the report calculates market share held by each of these regions. Furthermore, it identifies the leading region in this market.

Segments

The report segments the next generation sequencing market in terms of various parameters. The leading segment in each of these categories is identified in the study. Furthermore, their potential CAGR is calculated. In addition to this, the report offers insights into growth drivers and key restraints that are likely to impact the market across various segments.

Market Segmentations as below:

By Products and Services

  • NGS Platforms & Related Products
  • NGS Services

By Application

  • Oncology
  • Reproductive Health
  • Clinical Investigation
  • Immune System Monitoring
  • Agriculture & Animal Research
  • Epidemiology & Drug Development
  • Consumer Genomics

By Technology

  • Whole Genome Sequencing
  • Targeted Sequencing & Resequencing
  • Whole Exome Sequencing

By End Users

  • Academic Institutes & Research Centers
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Other users

By Geography

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Key Takeaways:

  • What is the market size in 2018 and the growth rate of this research report?
  • What is the market drivers, restrains, opportunities governing the global next generation sequencing market?
  • Which is the largest and the fastest growing segments in this report?
  • Who are the key players operating in the market and their market position?
  • What is the pipeline scenario, drug pricing analysis and technological development in the market?

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Next Generation sequencing
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Next Generation sequencing Market By Products and Services
1.2.2.1. Global Next Generation sequencing Market Revenue and Growth Rate Comparison By Products and Services (2015-2026)
1.2.2.2. Global Next Generation sequencing Market Revenue Share By Products and Services in 2018
1.2.2.3. NGS Platforms & Related Products
1.2.2.4. NGS Services
1.2.3. Next Generation sequencing Market By Application
1.2.3.1. Global Next Generation sequencing Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.3.2. Oncology
1.2.3.3. Reproductive Health
1.2.3.4. Clinical Investigation
1.2.3.5. Immune System Monitoring
1.2.3.6. Agriculture & Animal Research
1.2.3.7. Epidemiology & Drug Development
1.2.3.8. Consumer Genomics
1.2.4. Next Generation sequencing Market By Technology
1.2.4.1. Global Next Generation sequencing Market Revenue and Growth Rate Comparison By Technology (2015-2026)
1.2.4.2. Whole Genome Sequencing
1.2.4.3. Targeted Sequencing & Resequencing
1.2.4.4. Whole Exome Sequencing
1.2.5. Next Generation sequencing Market By End Users
1.2.5.1. Global Next Generation sequencing Market Revenue and Growth Rate Comparison By End Usersr (2015-2026)
1.2.5.2. Academic Institutes & Research Centers
1.2.5.3. Hospitals & Clinics
1.2.5.4. Pharmaceutical & Biotechnology Companies
1.2.5.5. Other users
1.2.6. Next Generation sequencing Market By Geography
1.2.6.1. Global Next Generation sequencing Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.6.2. North America Next Generation sequencing Market Revenue and Growth Rate(2015-2026)
1.2.6.3. Europe Next Generation sequencing Market Revenue and Growth Rate(2015-2026)
1.2.6.4. Asia-Pacific Next Generation sequencing Market Revenue and Growth Rate(2015-2026)
1.2.6.5. Latin America Next Generation sequencing Market Revenue and Growth Rate(2015-2026)
1.2.6.6. Middle East and Africa (MEA) Next Generation sequencing Market Revenue and Growth Rate(2015-2026)

CHAPTER 2. MARKET DYNAMICSAND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Next Generation sequencing Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Next Generation sequencing Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Next Generation sequencing Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Next Generation sequencing Major Manufacturers in 2018

CHAPTER 4. NEXT GENERATION SEQUENCING MARKET BY PRODUCTS AND SERVICES
4.1. Global Next Generation sequencing Revenue By Products and Services
4.2. NGS Platforms & Related Products
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. NGS Services
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. NEXT GENERATION SEQUENCING MARKET BY APPLICATION
5.1. Global Next Generation sequencing Revenue By Application
5.2. Oncology
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Reproductive Health
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Clinical Investigation
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Immune System Monitoring
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.6. Epidemiology & Drug Development
5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.7. Consumer Genomics
5.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. NEXT GENERATION SEQUENCING MARKET BY TECHNOLOGY
6.1. Global Next Generation sequencing Revenue By Technology
6.2. Whole Genome Sequencing
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Targeted Sequencing & Resequencing
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Whole Exome Sequencing
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NEXT GENERATION SEQUENCING MARKET By End Users
7.1. Global Next Generation sequencing Revenue By End Users
7.2. Academic Institutes & Research Centers
7.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.3. Hospitals & Clinics
7.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.4. Pharmaceutical & Biotechnology Companies
7.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.5. Other
7.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 8. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET BY COUNTRY
8.1. North America Next Generation sequencing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. North America Next Generation sequencing Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. U.S.
8.3.1. U.S. Next Generation sequencing Market Revenue and Forecast By Products and Services, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.3.4. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.4. Canada
8.4.1. Market Revenue and Forecast By Products and Services, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.4.4. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 9. EUROPE NEXT GENERATION SEQUENCING MARKET BY COUNTRY
9.1. Europe Next Generation sequencing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Europe Next Generation sequencing Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. UK
9.3.1. Market Revenue and Forecast By Products and Services, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.3.4. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.4. Germany
9.4.1. Market Revenue and Forecast By Products and Services, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.4.4. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.5. France
9.5.1. Market Revenue and Forecast By Products and Services, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.5.4. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.6. Spain
9.6.1. Market Revenue and Forecast By Products and Services, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.6.4. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.7. Rest of Europe
9.7.1. Market Revenue and Forecast By Products and Services, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.7.4. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 10. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET BY COUNTRY
10.1. Asia-Pacific Next Generation sequencing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Asia-Pacific Next Generation sequencing Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. China
10.3.1. Market Revenue and Forecast By Products and Services, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.3.4. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
10.4. Japan
10.4.1. Market Revenue and Forecast By Products and Services, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.4.4. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
10.5. India
10.5.1. Market Revenue and Forecast By Products and Services, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.5.4. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
10.6. Australia
10.6.1. Market Revenue and Forecast By Products and Services, 2015 - 2026 ($Million)
10.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.6.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.6.4. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
10.7. South Korea
10.7.1. Market Revenue and Forecast By Products and Services, 2015 - 2026 ($Million)
10.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.7.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.7.4. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
10.8. Rest of Asia-Pacific
10.8.1. Market Revenue and Forecast By Products and Services, 2015 - 2026 ($Million)
10.8.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.8.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.8.4. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 11. LATIN AMERICA NEXT GENERATION SEQUENCING MARKET BY COUNTRY
11.1. Latin America Next Generation sequencing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Latin America Next Generation sequencing Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Brazil
11.3.1. Market Revenue and Forecast By Products and Services, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.3.4. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
11.4. Mexico
11.4.1. Market Revenue and Forecast By Products and Services, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.4.4. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
11.5. Rest of Latin America
11.5.1. Market Revenue and Forecast By Products and Services, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.5.4. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 12. MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING MARKET BY COUNTRY
12.1. Middle East & Africa Next Generation sequencing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Middle East & Africa Next Generation sequencing Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. GCC
12.3.1. Market Revenue and Forecast By Products and Services, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.3.4. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
12.4. South Africa
12.4.1. Market Revenue and Forecast By Products and Services, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.4.4. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
12.5. Rest of Middle East & Africa
12.5.1. Market Revenue and Forecast By Products and Services, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.5.4. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE
13.1. BGI
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Bio-Rad Laboratories, Inc.
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. DNASTAR, Inc.
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Eurofins GATC Biotech GmbH
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. F Hoffman-La Roche Ltd.
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Genomatix GmbH, Illumina Inc.
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Oxford Nanopore Technologies
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Perkin Elmer, Inc.
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. PierianDx, Inc.
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. QIAGEN
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies
13.11. Thermo Fisher Scientific, Inc.
13.11.1. Company Snapshot
13.11.2. Overview
13.11.3. Financial Overview
13.11.4. Type Portfolio
13.11.5. Key Developments
13.11.6. Strategies
13.12. Others
13.12.1. Company Snapshot
13.12.2. Overview
13.12.3. Financial Overview
13.12.4. Type Portfolio
13.12.5. Key Developments
13.12.6. Strategies

CHAPTER 14. RESEARCH APPROACH
14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

The report is readily available and can be dispatched immediately after payment confirmation.

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1642

Contact Us:

Acumen Research and Consulting

Phone: +1 407 915 4157

Email: sales@acumenresearchandconsulting.com

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.